ASX:VRT

VIRTUS HEALTH LIMITED

Scott Power

The healthcare sector has been very strong this year, and here we touch on eight players within it. There have also been a couple of laggards in that space too, and they are the IVF players. So we've been sitting with neutral recommendations on the space the last two years.... Show More

CommSec

In this short video we discuss VRTs’ full year results, which saw NPAT attributable to ordinary equity holders down 14.6% to $28.1m and included a final dividend 12 cents per share fully franked; VRT’s position in the domestic market where it remains the overall leader with 42.1% share of the... Show More

Mathan Somasundaram

Local market ran into a brick wall after lunch despite solid China data. China Caxin Manufacturing data was better than expected and in expansion territory…good for commodities who had another good night. Bond yield proxies and currency proxies were under pressure from the start while banks joined the slide after... Show More

Livewire Exclusive

The consulting firm Quinlan and Associates recently estimated that brokers publish over 40,000 research reports globally each week. With reporting season in full flow now and for the next few weeks, this number may even feel on the low side. With research flow peaking we asked Rudi Filapek-Vandyck from FNArena,... Show More

Morgans Financial Limited

The healthcare sector has underperformed the broader market recently, but the fundamentals driving the sector remain the same. In the video below I discuss the healthcare stocks under Morgans coverage and provide a brief summary of our expectations leading into the 1H17 reporting season. Companies discussed include: ResMed, Cochlear, Sirtex... Show More

Morgans Financial Limited

This year saw outstanding results from the hospital operators, in particular, Ramsay Healthcare (RHC). Results were at the top end of consensus forecasts, and expectations are for continued robust growth. Over the last 20 year, RHC has produced an average of 16% compound earnings growth, and this looks like it... Show More

CommSec

Tom Piotrowski speaks with Virtus Health (VRT) CEO, Sue Channon about the company’s full year results and contributions from its operations in Singapore & Ireland To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series.html Show More

CommSec

CommSec’s Tom Piotrowski speaks with Virtus Health (VRT) CEO, Sue Channon about the IVF company’s first half results and plans to grow its international business To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series.html Show More

Scott Power

Monthly IVF cycle numbers for April were released yesterday, highlighting a much needed bounce across the board of 7.4% on pcp to 3,480 cycles, mainly driven from a bounce back in NSW cycles, up 12.6% on pcp. This produces a 12 month rolling change of 0.2% to April 2015, turning... Show More